secwatch.observer — SEC 8-K summary
======================================

Issuer:     FILANA THERAPEUTICS, INC. (FLNA)
CIK:        0001069530
Form:       8-K
Filed at:   2022-11-22T23:59:59+00:00
Accession:  0001069530-22-000061
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cassava Sciences closes $50M registered direct offering of 1.67M shares at $30/share
--------------------------------------------------------------------------------

- Gross proceeds ~$50M from 1,666,667 shares at $30; net proceeds ~$47.3M after fees.
- H.C. Wainwright acted as exclusive placement agent; JonesTrading and Perella Weinberg as advisors.
- Proceeds to fund working capital and development of simufilam, its lead Alzheimer's candidate.
- Offering closed Nov. 22, 2022; shares sold under existing shelf registration statement.
- 90-day lock-up on company share sales; prohibition on variable-rate transactions for 90 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069530/000106953022000061/0001069530-22-000061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069530/000106953022000061/sava-20221118x8k.htm
  HTML page:      https://secwatch.observer/filing/0001069530-22-000061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer